DA
DXCM icon

Duality Advisers’s DexCom DXCM Stock Holding History

Duality Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,321
Closed -$5.13M – 635
2023
Q4 		$5.13M Buy
+41,321
New +$4.22M 0.54% 30
2023
Q3 		– Sell
-10,562
Closed -$1.36M – 602
2023
Q2 		$1.36M Buy
+10,562
New +$1.28M 0.17% 228
2023
Q1 		– Sell
-34,337
Closed -$3.89M – 614
2022
Q4 		$3.89M Buy
+34,337
New +$3.77M 0.44% 48
2022
Q1 		– Sell
-5,272
Closed -$708K – 678
2021
Q4 		$708K Buy
+5,272
New +$758K 0.08% 351
2021
Q3 		– Sell
-24,600
Closed -$2.63M – 580
2021
Q2 		$2.63M Buy
24,600
+20,380
+483% +$1.96M 0.23% 145
2021
Q1 		$379K Buy
4,220
+488
+13% +$45.8K 0.03% 477
2020
Q4 		$345K Sell
3,732
-548
-13% -$48.9K 0.03% 486
2020
Q3 		$441K Buy
+4,280
New +$447K 0.03% 491

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Duality Advisers's DXCM Position: Q1 2024 in Review

Duality Advisers sold out of DexCom (DXCM) in Q1 2024, closing a stake of 41,321 shares — an estimated $5.13M sold.

Duality Advisers first reported a position in DXCM in Q3 2020 and held it in 8 quarters. The position peaked at $5.13M in Q4 2023. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Duality Advisers reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Duality Advisers sold 41,321 DexCom shares in Q1 2024, an estimated $5.13M.
  • Duality Advisers first reported a position in DexCom in Q3 2020 and held it in 8 quarters.
  • Duality Advisers's DexCom position peaked at $5.13M in Q4 2023.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Duality Advisers's 13F filing for Q1 2024, filed 6 May 2024.